8-K: MicroVision Enters $150 Million At-The-Market Offering Agreement, Terminates Previous Agreement
Capital Raise Announcement
MicroVision has entered into a new at-the-market offering agreement to sell up to $150 million in common stock, while terminating a previous agreement with Craig-Hallum.
Summary
- MicroVision, Inc. has entered into an At-The-Market Issuance Sales Agreement with Deutsche Bank Securities Inc., Mizuho Securities USA LLC, and Craig-Hallum Capital Group LLC, allowing the company to sell up to $150 million of its common stock.
- The sales will be made through the agents or directly to them, under the company's existing registration statement.
- The company will pay a 3% commission to the agents for shares sold through them in agency transactions.
- MicroVision also terminated a previous at-the-market sales agreement with Craig-Hallum, under which it sold approximately 6.1 million shares for $16 million.
- The net proceeds from the new offering are intended to support investments in scaling production, accelerating ASIC development, and advancing the go-to-market strategy for MAVIN and MOVIA products, as well as for general corporate purposes.
Sentiment
Score: 6
Explanation: The document is neutral to slightly positive. While the capital raise is dilutive, it is a necessary step for the company's growth plans. The clear use of proceeds and the termination of the previous agreement without penalty are positive signs.
Positives
- The new agreement provides MicroVision with access to up to $150 million in capital.
- The company has a clear plan for the use of the proceeds, focusing on growth and product development.
- The termination of the previous agreement did not result in any penalty to the company.
Negatives
- The offering will dilute existing shareholders.
- The company will incur a 3% commission on shares sold through agents.
- There is no guarantee that the company will sell all the shares under the agreement.
Risks
- The company's ability to successfully complete the offering on satisfactory terms is not guaranteed.
- The market price of the company's shares could be adversely impacted by the dilutive effect of the offering.
- The company faces capital market risks and may need to raise additional capital in the future.
- There is a risk that the company's commercial partners may not perform as expected.
- The company's ability to keep up with rapid technological change is a risk factor.
Future Outlook
The company anticipates using the net proceeds to support investments in scaling production capabilities, accelerating application-specific integrated circuit development, and advancing its go-to-market strategy for both its MAVIN and MOVIA products, as well as for other general corporate purposes.
Industry Context
At-the-market offerings are a common method for publicly traded companies to raise capital, especially in the technology sector. This allows companies to sell shares gradually into the market, potentially minimizing the impact on the stock price compared to a traditional secondary offering. The funds raised are often used to support growth initiatives, research and development, or general corporate purposes.
Comparison to Industry Standards
- At-the-market offerings are a common practice for companies seeking flexible access to capital, particularly in the tech sector.
- The 3% commission rate is within the typical range for such offerings.
- The stated use of proceeds for scaling production and R&D is consistent with industry norms for growth-oriented tech companies.
- Comparable companies such as Luminar Technologies and Velodyne Lidar have also utilized similar financing methods to fund their operations and growth.
Stakeholder Impact
- Shareholders will experience dilution due to the issuance of new shares.
- Employees may benefit from the company's growth and development plans.
- Customers may see improved products and services as a result of the investments.
- Suppliers may see increased business opportunities with the company.
- Creditors may be impacted by the company's increased debt or equity.
Next Steps
- MicroVision will begin selling shares under the new at-the-market agreement.
- The company will use the proceeds to fund its growth initiatives.
- The company will continue to file required reports with the SEC.
Key Dates
| Date | Description |
|---|---|
| 2023-06-13 | Date of the initial filing of the Registration Statement on Form S-3. |
| 2023-08-29 | Date of the terminated At-The-Market Issuance Sales Agreement with Craig-Hallum. |
| 2024-02-29 | Date of Post-Effective Amendment No. 1 to the Registration Statement. |
| 2024-03-01 | Date of Post-Effective Amendment No. 2 to the Registration Statement. |
| 2024-03-05 | Date of the new At-The-Market Issuance Sales Agreement and termination of the previous agreement. |
Keywords
at-the-market offering, capital raise, common stock, share dilution, sales agreement, MicroVision, MAVIN, MOVIA, ASIC development, production scaling
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.